Abstract :
Bleomycin is a primary nonsurgical therapy option for head and neck lymphangiomas. The goal of this study is to evaluate its efficacy and look into any potential side effects. At this case series inquiry, three patients who were diagnosed with head and neck lymphangioma were seen at the ENT department. They underwent clinical and radiological evaluations before being treated with an intralesional injection of bleomycin diluted in normal saline. Full resolution and a good response were shown by all three people. There were no notable issues, except from fever. Bleomycin may be the primary treatment choice when used intralesionally.
Keyword :
Bleomycin, Sclerotherapy, Lymphangioma, Surgery.